THRIVE Use in Pediatric Populations- Multi Site

Completed · Not applicable

Conditions studied: Oxygen Deficiency, Desaturation of Blood, Hypoventilation, Anesthesia; Adverse Effect

In brief

THRIVE (Transnasal Humidified Rapid-Insufflation Ventilatory Exchange) refers to the use of high-flow nasal cannula to augment the ability to oxygenate and ventilate a patient under general anesthesia. The use of high-flow nasal cannula oxygen supplementation during anesthesia for surgical procedures has been a recent development in the adult population, with limited data analyzing the pediatric population. This study will determine whether high flow nasal cannula oxygen supplementation during surgical or endoscopic procedures can prevent desaturation events in children under anesthesia and improve the outcomes of that surgery.

Key facts

Study ID
NCT04322994
Run by
Stanford University
People needed
175
Starts
2020-10-21
Expected to finish
2024-01-19
Last updated by the study team
2025-03-27

Who can join

Age: any, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.